The global polymerase chain reaction technology market size was $16,669.3 million in 2020, and is expected to reach $28,755.1 million by 2030, with a CAGR of 4.1% from 2021 to 2030. Polymerase chain reaction (PCR) is a huge consistent methodology in the molecular biological science that upgrades single or barely any copies of a piece of DNA. Similarly, it is valuable in making thousands to millions of copies of a particular DNA gathering and investigating ailments such as AIDS, tuberculosis, Lyme disorder, and center ear infections. The development incorporates three huge advances; denaturation, hardening, and extension. It is applicable in clinical, research, clinical diagnostics, and legitimate sciences. It has been utilized since seemingly forever as a standard method for research on nucleic acids (RNA and DNA) in labs. PCR progresses available in the market are nonstop quantitative (qPCR), mechanized PCR (dPCR), computerized PCR, multiplex PCR, gathering PCR, and standard PCR. The need of strong illustrative diagnostic system in clinical consideration to perceive ailments empowers the premium for the advancement of the market.
Advancement in growth of infection and overwhelming contamination drive the polymerase chain reaction technologies market. For instance, cancer is one of the primary reasons of death across the globe. As per the National Cancer Institute, numerous people experience the ill effects of cancer. On account of the climb in the amount of patients encountering consistent contaminations, there is a development in the premium for PCR headways for the early investigation of sicknesses. From now on, various institutions have started with the therapy at the earliest, with the development in the inescapability of the infections. There is development in the interest in PCR advancements to perceive these afflictions toward the starting stages. Consequently, this positively impacts the development of the market. In addition, the progression in PCR propels by key part in industry help the advancement of the market by making advanced solutions open to the clinical services specialists for acknowledgment of various kinds of powerful disorders, threatening development, blood screening, and various applications, which drive the polymerase chain reaction technology market.
However, PCR tests can be used for the examination of various contaminations. Regardless, the cost related with the use of PCR progressions for the indicative tests are high. Consequently, patients do not select such tests. In like manner, various countries do not give reimbursement to these tests. The execution of these rates would achieve decline in reimbursement for key molecular tests, including inherited disease, molecular cytogenetics, and cancer testing. Consequently, nonappearance of reimbursements options further hinders the polymerase chain reaction technologies market growth for PCR developments.
On the contrary, the ascent in the occurrence of the infection and sicknesses such as cancer growth and contamination has expanded the interest of the characteristic techniques that could help in the early acknowledgment of these diseases. This has incited a development in sponsoring for the R&D activities that could help in the early finding of these diseases. In addition, critical associations put assets into the progress of the molecular diagnostics, for instance, PCR, expecting the development and demand in the field. The extension in sponsoring for R&D practices that incorporates the use of PCR for various purposes could extend the use of these advances and could offer new polymerase chain reaction technologies opportunity.
The Polymerase chain reaction technology market is segmented on the basis of technology, product, application, end user industry, and region. By technology, the market is divided into real-time PCR, traditional PCR, and digital PCR. By product, the market is fragmented into reagents & consumables, instruments, software, and services. By application, the market is classified into clinical, research, and forensics. By end user, the market is divided into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, South Korea, India, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
The major players profiled in the polymerase chain reaction technology market include Abcam plc. (Expedeon AG), Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Fluidigm, LGC Limited, Qiagen, Takara Bio Inc., Thermo Fisher Scientific Inc.Major companies in the market have adopted product launch, partnership, and agreement as their key developmental strategies to offer better products and services to customers in the Polymerase chain reaction technology market.
Advancement in growth of infection and overwhelming contamination drive the polymerase chain reaction technologies market. For instance, cancer is one of the primary reasons of death across the globe. As per the National Cancer Institute, numerous people experience the ill effects of cancer. On account of the climb in the amount of patients encountering consistent contaminations, there is a development in the premium for PCR headways for the early investigation of sicknesses. From now on, various institutions have started with the therapy at the earliest, with the development in the inescapability of the infections. There is development in the interest in PCR advancements to perceive these afflictions toward the starting stages. Consequently, this positively impacts the development of the market. In addition, the progression in PCR propels by key part in industry help the advancement of the market by making advanced solutions open to the clinical services specialists for acknowledgment of various kinds of powerful disorders, threatening development, blood screening, and various applications, which drive the polymerase chain reaction technology market.
However, PCR tests can be used for the examination of various contaminations. Regardless, the cost related with the use of PCR progressions for the indicative tests are high. Consequently, patients do not select such tests. In like manner, various countries do not give reimbursement to these tests. The execution of these rates would achieve decline in reimbursement for key molecular tests, including inherited disease, molecular cytogenetics, and cancer testing. Consequently, nonappearance of reimbursements options further hinders the polymerase chain reaction technologies market growth for PCR developments.
On the contrary, the ascent in the occurrence of the infection and sicknesses such as cancer growth and contamination has expanded the interest of the characteristic techniques that could help in the early acknowledgment of these diseases. This has incited a development in sponsoring for the R&D activities that could help in the early finding of these diseases. In addition, critical associations put assets into the progress of the molecular diagnostics, for instance, PCR, expecting the development and demand in the field. The extension in sponsoring for R&D practices that incorporates the use of PCR for various purposes could extend the use of these advances and could offer new polymerase chain reaction technologies opportunity.
The Polymerase chain reaction technology market is segmented on the basis of technology, product, application, end user industry, and region. By technology, the market is divided into real-time PCR, traditional PCR, and digital PCR. By product, the market is fragmented into reagents & consumables, instruments, software, and services. By application, the market is classified into clinical, research, and forensics. By end user, the market is divided into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, South Korea, India, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
The major players profiled in the polymerase chain reaction technology market include Abcam plc. (Expedeon AG), Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Fluidigm, LGC Limited, Qiagen, Takara Bio Inc., Thermo Fisher Scientific Inc.Major companies in the market have adopted product launch, partnership, and agreement as their key developmental strategies to offer better products and services to customers in the Polymerase chain reaction technology market.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the polymerase chain reaction technologies market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the polymerase chain reaction technologies market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global polymerase chain reaction technologies market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End Users
- Diagnostic Centers Hospitals
- Biotech Pharma Companies
- Academic Research Institutions
By Technology
- Real-Time PCR
- Traditional PCR
- Digital PCR
By Product
- Reagents Consumables
- Instruments
- Software
- Services
By Region
- Europe
- Germany
- United Kingdom
- France
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- North America
- U.S.
- Canada
- Mexico
- LAMEA
- Latin America
- Middle East
- Africa
Key Market Players
- AGILENT TECHNOLOGIES
- INC
- BIOMERIEUX S.A
- BIO-RAD LABORATORIES
- INC
- F. HOFFMANN-LA ROCHE AG (ROCHE)
- FLUIDIGM CORPORATION
- LGC LIMITED
- QIAGEN N.V
- SYGNIS AG
- TAKARA BIO INC
- THERMO FISHER SCIENTIFIC INC
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY TECHNOLOGY
CHAPTER 5: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY PRODUCT
CHAPTER 6: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY END USERS
CHAPTER 7: POLYMERASE CHAIN REACTION TECHNOLOGIES MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Polymerase Chain Reaction Technologies Market,' the polymerase chain reaction technologies market size was valued at $16.7 billion in 2020, and is estimated to reach $28.8 billion by 2030, growing at a CAGR of 4.1% from 2021 to 2030. Polymerase chain reaction (PCR) is a gigantic steady system in the molecular biological science that redesigns single or scarcely any duplicates of a piece of DNA. Moreover, it is important in making thousands to millions of duplicates of a specific DNA assembling and examining illnesses such as AIDS, tuberculosis, Lyme problem, and focus ear contaminations. The improvement joins three immense advances denaturation, solidifying, and expansion. It is applicable in clinical, research, clinical diagnostics, and authentic sciences. It has been used since apparently perpetually as a standard technique for research on nucleic acids (RNA and DNA) in labs. PCR advances accessible in the market are constant quantitative (qPCR), automated PCR (dPCR), mechanized PCR, multiplex PCR, gathering PCR, and standard PCR. The need of solid illustrative analytic framework in clinical systems to see infirmities enables the progression of the polymerase chain reaction (PCR) technologies market.The progressions in PCR advances by key players in industry help the development of the market by making progressed items accessible to the medical services experts for recognition of different sorts of irresistible sicknesses, malignant growth, blood screening, and different applications. In addition, development in occurrence of malignant growth and irresistible infection drive the polymerase chain response innovationsin the polymerase chain reaction technologies market. For instance, cancer is one of the main reasons of death across the globe. According to the National Cancer Institute, many individuals suffer from cancer due to contamination. Owing to the ascent in the quantity of patients experiencing constant infections, there is an expansion in the interest in PCR advancements for early analysis of illnesses. Henceforth, different associations start with the treatment at the earliest, with expansion in the pervasiveness of sicknesses around the world. There is an expansion in the interest in PCR innovations to recognize these sicknesses at the beginning phases. Hence, this is positively impacting the polymerase chain reaction technologies market growth.
However, PCR tests can be utilized for the assessment of different infections. In any case, the expense related with the utilization of PCR systems for the demonstrative tests are high. Therefore, patients do not choose such tests. Moreover, different nations go not give repayment to these tests. The execution of these rates would accomplish decrease in repayment for key molecular tests, including inherited disease, molecular cytogenetics, and cancer testing. Thus, nonappearance of repayments choices further hinders the polymerase chain reaction technologies market growth for PCR advancements.
In addition, the outbreak of COVID-19 has led to halt in logistic and manufacturing activities across the globe, which, in turn, has led to interruption of supply chain. However the polymerase chain reaction technologies market increased rapidly owing its application in testing COVID infections.
On the contrary, the growth in the occurrence of the contamination and ailments such as cancer development has extended the interest of the procedures that could help in the early affirmation of these illnesses. This has impelled an improvement in support of the R&D activities that could help in the early finding of these illnesses. Moreover, basic affiliations put resources into the advancement of the sub-molecular diagnostics, for instance, PCR is utilizing the need of diagnostics and clinical applications. The augmentation in support for R&D rehearses that joins the utilization of PCR for different purposes could expand the utilization of these advances and could offer new polymerase chain reaction technologies market opportunities.
The polymerase chain reaction technologies market share is segmented on the basis of technologies, product, application, end user industry, and region. By technologies, the market is divided into real-time PCR, traditional PCR, and digital PCR. By Product, the market is segmented into reagents & consumables, instruments, software, and services. By end user, the market is divided into diagnostic centers & hospitals, biotech & pharma companies, and academic & research institutions. Region wise, the global polymerase chain reaction technologies market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
The major players profiled in the polymerase chain reaction industry include Abcam plc. (Expedeon AG), Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Fluidigm, LGC Limited, Qiagen, Takara Bio Inc., Thermo Fisher Scientific Inc.
Key findings of the Study
- The report provides an extensive analysis of the current and emerging global opportunities in the polymerase chain reaction technologies market.
- Depending on technologies, the real-time PCR segment was the largest revenue generator in 2020.
- By product, the reagents & consumables segment generated the highest revenue in 2020.
- The report provides an extensive analysis of the global polymerase chain reaction technologies market trends and emerging opportunities of the market
- The global polymerase chain reaction technologies market forecast from 2021 to 2030 is included in the report.
Companies Mentioned
- AGILENT TECHNOLOGIES Inc.
- BIOMERIEUX S.A
- BIO-RAD LABORATORIES Inc.
- F. HOFFMANN-LA ROCHE AG (ROCHE)
- FLUIDIGM CORPORATION
- LGC LIMITED
- QIAGEN N.V
- SYGNIS AG
- TAKARA BIO INC
- THERMO FISHER SCIENTIFIC INC
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 230 |
| Published | March 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 19240.11 million |
| Forecasted Market Value ( USD | $ 28755.1 million |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
